Rostock, Germany, March 28, 2013 --(PR.com
)-- Graeme Daniels, Sales Director at Cytocentrics, said “We are extremely happy to have found a company of SciPro’s calibre to work with to bring our new CytoPatch2 automated patch clamp system to the North American market. There are clear synergies between our two companies, a shared business philosophy and a desire to exceed our customer’s expectations, that I am sure will be the basis of a long and fruitful partnership.”
Adrian Grant, Owner of SciPro Inc, said “SciPro is indeed pleased to be partnering with Cytocentrics. Not only do we believe that the innovative technology provided by the Cytopatch2 will be of great benefit to both our existing and future customers but Cytocentrics’ strong commitment to customer support and product development will ensure a long, solid future.”
SciPro is a team of professionals with more than 25 years’ experience in serving scientists in NA. With offices in both the US & Canada we are dedicated to offering products of the highest quality and support. As scientists, we recognize the necessity for a source of specialty accessories and unique instruments. Our mission is to provide the highest value, service & support at a fair price.
For more information about SciPro please visit www.scipro.com
Cytocentrics Bioscience GmbH is a team of scientists, engineers and business professionals who apply our expertise to support our customers by supplying cutting edge automated patch clamp systems, ion channel cell lines, patch clamp reagents and ion channel screening services. Our wholly owned subsidiary, Cytocentrics BV, is a micro- and nano-technology service provider offering foundry service, design consultancy, prototyping and production of MEMS/MST (MicroElectroMechanical Systems / MicroSystemsTechnology) products for Original Equipment Manufacturer clients in the Life Science, Medical Devices and Diagnostics industries.
For further information please contact our Sales office:
Cytocentrics Bioscience GmbH
Tel. +31 40 8515532
For more information about Cytocentrics and the CytoPatch² please visit us at www.cytocentrics.com